EUDA Health Announces 1-for-20 Reverse Stock Split to Boost Share Price for Nasdaq Compliance

summarizeSummary

EUDA Health Holdings Ltd. will implement a 1-for-20 reverse stock split, effective March 23, 2026, to increase its share price and maintain Nasdaq listing compliance.

check_boxKey Events

• Reverse Stock Split Approved

  The Board of Directors approved a 1-for-20 reverse stock split of the company's ordinary shares.

• Effective Date

  The reverse stock split will become effective at market open on March 23, 2026, with shares trading on a split-adjusted basis on the Nasdaq Capital Market.

• Share Count Reduction

  The number of outstanding ordinary shares will be reduced from approximately 50.3 million to 2.5 million post-split.

• Warrant Adjustments

  The terms of existing warrants will be proportionately adjusted, reducing the number of underlying shares and increasing the exercise price.

auto_awesomeAnalysis

This reverse stock split is a critical move for EUDA Health, a nano-cap company, to meet Nasdaq's minimum bid price requirement. While it does not alter the company's fundamental value or a shareholder's proportional ownership, reverse splits are typically viewed negatively by the market as they often signal underlying financial challenges or a struggle to maintain investor confidence. The adjustment of warrant terms is a standard consequence of such a corporate action. Investors should monitor the stock's performance post-split and the company's ability to leverage its existing ATM program effectively at the new price level.